Ousenu Karimo, Ali Innocent Mbulli, Sama Leonard Fonkeng, Ndam Marcel Nsangou, Tchouangueu Thibau Florant, Tume Christopher Bonglavnyuy
Research Unit of Microbiology and Antimicrobial Substances, Department of Biochemistry, Faculty of Science, University of Dschang, Dschang, Cameroon.
MARCAD Program, The Biotechnology Centre, University of Yaoundé 1, Yaoundé, Cameroon.
Can J Infect Dis Med Microbiol. 2021 Aug 7;2021:8279122. doi: 10.1155/2021/8279122. eCollection 2021.
The diagnosis of typhoid fever based on the Widal slide agglutination test remains a major hurdle in developing countries due to varied perceptions of the value of the Widal test in determining clinical decision-making. We undertook a study to evaluate the diagnostic performance of the Widal test and the Typhidot immunoassay in patients suspected of having typhoid fever in the Menoua division, West Region of Cameroon.
Blood and stool samples were collected from 558 consenting febrile patients on the basis of suspicion of typhoid fever. These patients attended three district health services of the Menoua division between April 2018 and September 2019. These patients had clinical symptoms suggestive of typhoid fever as determined by their consultant. Serum was used for the Widal slide agglutination test and for the Typhidot rapid immunoassay test based on manufacturer's guidelines. A composite reference of fever plus positive coproculture for and was used as the reference. The sensitivity, specificity, and predictive values of the positive and negative tests were calculated as well as Cohen's kappa for agreement between the two tests.
Of 558 patients, 12.90% tested positive for the reference method, 57.17% tested positive for the Widal slide agglutination test, while 15.59% were positive for Typhidot-IgM. The overall sensitivity, specificity, and predictive values of the positive and negative tests were 80.56%, 94.03%, 66.6%, and 97.03% for Typhidot-IgM and 94.44%, 48.35%, 21.32%, and 98.33% for the Widal slide agglutination test, respectively. Cohen's kappa estimates were 0.1660 (0.121-0.211) and 0.386 (0.312-0.460) for the Widal test and Typhidot immunoassay for 53.6% and 76.16% agreements of all observations, respectively.
The Widal test was found to have a lower predictive value for the diagnosis of typhoid fever in our setting. However, the Typhidot test, although better, was not ideal. Diagnosis of typhoid fever should therefore rely on adequate clinical suspicion and a positive Typhidot test to improve the clinical management of typhoid fever in our setting.
由于对肥达氏玻片凝集试验在临床决策中的价值存在不同看法,在发展中国家,基于该试验诊断伤寒热仍是一个主要障碍。我们开展了一项研究,以评估肥达氏试验和伤寒Dot免疫测定法在喀麦隆西部地区梅努阿分区疑似伤寒热患者中的诊断性能。
基于对伤寒热的怀疑,从558名同意参与的发热患者中采集血液和粪便样本。这些患者在2018年4月至2019年9月期间前往梅努阿分区的三个地区卫生服务机构就诊。经其会诊医生判断,这些患者具有提示伤寒热的临床症状。根据制造商的指南,血清用于肥达氏玻片凝集试验和伤寒Dot快速免疫测定试验。以发热加粪便培养阳性作为参考标准。计算了阳性和阴性试验的敏感性、特异性和预测值,以及两种试验之间一致性的Cohen's kappa值。
在558名患者中,12.90%的患者参考方法检测呈阳性,57.17%的患者肥达氏玻片凝集试验检测呈阳性,而伤寒Dot - IgM检测呈阳性的患者为15.59%。伤寒Dot - IgM阳性和阴性试验的总体敏感性、特异性和预测值分别为80.56%、94.03%、66.6%和97.03%,肥达氏玻片凝集试验分别为94.44%、48.35%、21.32%和98.33%。在所有观察结果中,肥达氏试验和伤寒Dot免疫测定法的Cohen's kappa估计值分别为0.1660(0.121 - 0.211)和0.386(0.312 - 0.460),一致性分别为53.6%和76.16%。
在我们的研究环境中,发现肥达氏试验对伤寒热诊断的预测价值较低。然而,伤寒Dot试验虽然较好,但并不理想。因此,伤寒热的诊断应依靠充分的临床怀疑和伤寒Dot试验阳性,以改善我们研究环境中伤寒热的临床管理。